St. Jude Medical’s Confirm
This article was originally published in The Gray Sheet
Executive Summary
Firm plans an October launch of its Confirm implantable cardiac monitor, which received 510(k) clearance on Sept. 11. About the size of a typical "computer thumb drive" and implanted under the skin in the upper chest, the device allows physicians to evaluate heart rhythm over a longer period of time than standard tests, the firm says. Patients can send the data remotely to their physicians when they experience symptoms
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.